Related Experiment Video

Updated: Aug 24, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Molecular biological design of novel antineoplastic therapies

Michel Vulfovich1, Nabil Saba

  • 1Emory University School of Medicine and Winship Cancer Institute, Crawford Long Hospital, 550 Peachtree Street, Glenn Building, Atlanta, GA, USA.

Expert Opinion on Investigational Drugs
|June 4, 2004
PubMed

Insights

Novel anticancer therapies, including monoclonal antibodies and tyrosine kinase inhibitors, offer targeted treatment strategies. These innovative drugs show promise in stabilizing tumor progression with reduced systemic toxicities, representing a new era in cancer care.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer treatment traditionally relies on cytotoxic chemotherapy.
  • Advances in molecular biology reveal specific targets for drug development.
  • There is a need for anticancer agents with improved efficacy and reduced side effects.

Purpose of the Study:

  • To review novel therapeutic strategies for cancer treatment.
  • To discuss the mechanisms of action and clinical trials of emerging anticancer agents.
  • To evaluate the potential benefits and toxicities of these novel therapies.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of mechanisms of action for various novel drug classes.
  • Summary of key clinical trial outcomes and safety profiles.

Main Results:

  • Monoclonal antibodies, tyrosine kinase inhibitors, and other targeted agents demonstrate significant anticancer activity.
  • These novel therapies can prolong or stabilize tumor progression.
  • Many novel agents exhibit improved toxicity profiles compared to conventional chemotherapy.

Conclusions:

  • Novel therapeutic agents represent a promising advancement in oncology.
  • Targeted mechanisms offer new perspectives for cancer treatment.
  • Further research and clinical application of these agents are warranted.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...